Cargando…
Effect of Vitamin D Supplements on Relapse or Death in a p53-Immunoreactive Subgroup With Digestive Tract Cancer: Post Hoc Analysis of the AMATERASU Randomized Clinical Trial
IMPORTANCE: Recent meta-analyses of randomized clinical trials found that daily vitamin D3 supplementation had beneficial effects on cancer mortality, although the results are still controversial. OBJECTIVE: To examine whether vitamin D supplementation reduces the risk of relapse or death in a supgr...
Autores principales: | Kanno, Kazuki, Akutsu, Taisuke, Ohdaira, Hironori, Suzuki, Yutaka, Urashima, Mitsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445201/ https://www.ncbi.nlm.nih.gov/pubmed/37606927 http://dx.doi.org/10.1001/jamanetworkopen.2023.28886 |
Ejemplares similares
-
Effect of Vitamin D Supplements on Relapse of Digestive Tract Cancer with Tumor Stromal Immune Response: A Secondary Analysis of the AMATERASU Randomized Clinical Trial
por: Akutsu, Taisuke, et al.
Publicado: (2021) -
Effect of Serum SPARC Levels on Survival in Patients with Digestive Tract Cancer: A Post Hoc Analysis of the AMATERASU Randomized Clinical Trial
por: Akutsu, Taisuke, et al.
Publicado: (2020) -
Effect Modification of Vitamin D Supplementation by Histopathological Characteristics on Survival of Patients with Digestive Tract Cancer: Post Hoc Analysis of the AMATERASU Randomized Clinical Trial
por: Yonaga, Hideyuki, et al.
Publicado: (2019) -
Applying Machine Learning to Determine 25(OH)D Threshold Levels Using Data from the AMATERASU Vitamin D Supplementation Trial in Patients with Digestive Tract Cancer
por: Otani, Katharina, et al.
Publicado: (2022) -
Effect of Vitamin D Supplementation on Survival of Digestive Tract Cancer Patients with Low Bioavailable 25-Hydroxyvitamin D Levels: A Post Hoc Analysis of the AMATERASU Randomized Clinical Trial
por: Urashima, Mitsuyoshi, et al.
Publicado: (2020)